Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France

View ORCID ProfileLaura Di Domenico, Chiara E. Sabbatini, View ORCID ProfileGiulia Pullano, Daniel Lévy-Bruhl, View ORCID ProfileVittoria Colizza
doi: https://doi.org/10.1101/2021.02.14.21251708
Laura Di Domenico
1INSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laura Di Domenico
Chiara E. Sabbatini
1INSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giulia Pullano
1INSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France
2Orange Labs, Sociology and Economics of Networks and Services (SENSE), Chatillon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Giulia Pullano
Daniel Lévy-Bruhl
3Santé publique France, Saint-Maurice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vittoria Colizza
1INSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France
4Tokyo Tech World Research Hub Initiative, Institute of Innovative Research, Tokyo Institute of Technology, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vittoria Colizza
  • For correspondence: vittoria.colizza{at}inserm.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Data Availability

All data are available at the references cited.

Back to top
PreviousNext
Posted March 10, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France
Laura Di Domenico, Chiara E. Sabbatini, Giulia Pullano, Daniel Lévy-Bruhl, Vittoria Colizza
medRxiv 2021.02.14.21251708; doi: https://doi.org/10.1101/2021.02.14.21251708
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France
Laura Di Domenico, Chiara E. Sabbatini, Giulia Pullano, Daniel Lévy-Bruhl, Vittoria Colizza
medRxiv 2021.02.14.21251708; doi: https://doi.org/10.1101/2021.02.14.21251708

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (576)
  • Allergy and Immunology (868)
  • Anesthesia (306)
  • Cardiovascular Medicine (4482)
  • Dentistry and Oral Medicine (449)
  • Dermatology (385)
  • Emergency Medicine (615)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1528)
  • Epidemiology (15278)
  • Forensic Medicine (31)
  • Gastroenterology (1133)
  • Genetic and Genomic Medicine (6645)
  • Geriatric Medicine (671)
  • Health Economics (1006)
  • Health Informatics (4605)
  • Health Policy (1378)
  • Health Systems and Quality Improvement (1623)
  • Hematology (544)
  • HIV/AIDS (1276)
  • Infectious Diseases (except HIV/AIDS) (15961)
  • Intensive Care and Critical Care Medicine (1111)
  • Medical Education (626)
  • Medical Ethics (147)
  • Nephrology (674)
  • Neurology (6695)
  • Nursing (346)
  • Nutrition (1006)
  • Obstetrics and Gynecology (1153)
  • Occupational and Environmental Health (961)
  • Oncology (3369)
  • Ophthalmology (988)
  • Orthopedics (370)
  • Otolaryngology (421)
  • Pain Medicine (437)
  • Palliative Medicine (131)
  • Pathology (669)
  • Pediatrics (1704)
  • Pharmacology and Therapeutics (700)
  • Primary Care Research (717)
  • Psychiatry and Clinical Psychology (5495)
  • Public and Global Health (9285)
  • Radiology and Imaging (2223)
  • Rehabilitation Medicine and Physical Therapy (1375)
  • Respiratory Medicine (1201)
  • Rheumatology (598)
  • Sexual and Reproductive Health (721)
  • Sports Medicine (535)
  • Surgery (722)
  • Toxicology (100)
  • Transplantation (290)
  • Urology (267)